Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors

Human Pathology
W C HungL Y Chuang

Abstract

The expression of cyclin D1 gene product in human ovarian tumors was studied. We found that cyclin D1 is expressed at high levels in several ovarian cancer cell lines. Immunohistochemical study also showed that a significant proportion of primary ovarian tumor tissues overexpressed cyclin D1 gene product. Clear nuclear staining of cyclin D1 protein was detected in 28% of the cases. We also characterized the expression of c-Ki-ras gene product in ovarian cancer cell lines and tumor tissues. Amplification or overexpression of this proto-oncogene has been reported in ovarian tumors from Taiwan. These results show that c-Ki-ras is strongly expressed in PA-1 and NIH:OVCAR-3 cells in which cyclin D1 also expressed at high levels. Specific cytoplasmic staining of c-Ki-ras protein was detected in 11 tumors (52%). Statistical analyses show a strong positive correlation between cyclin D1 and c-Ki-ras immunoexpression. Thus, these data support the ideas that cyclin D1 may be involved in the pathogenesis of ovarian cancer, and coactivation of cyclin D1 and c-Ki-ras gene expression may represent one of the major pathways that lead to the development of ovarian cancer in Taiwan.

References

Sep 20, 1991·Cell·T Hunter, J Pines
Jun 18, 1993·Cell·C J Sherr
Nov 15, 1995·Cancer·H H GallionJ R van Nagell

❮ Previous
Next ❯

Citations

Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C-H ChenS-N Chow
Jan 25, 2000·Journal of Clinical Pathology·M M KennedyJ J O'Leary
Jun 13, 1998·Molecular Pathology : MP·R Donnellan, R Chetty
Jun 6, 2002·American Journal of Clinical Pathology·Armando C FilieAndrea Abati
Jul 4, 2008·Critical Reviews in Oncology/hematology·Angiolo GadducciAndrea Riccardo Genazzani
Jun 15, 2011·The Biochemical Journal·Maria V BarbolinaM Sharon Stack
Sep 5, 2001·Gynecologic Oncology·E CasadoD T Curiel
Jun 1, 2000·Gynecologic Oncology·M J SchmitzM J Birrer
Mar 22, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Ana-Maria BambergerThomas Löning
Dec 8, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R A SoslowR N Baergen
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. K. DharP. R. Hoban
Jun 27, 2008·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Hermann Brustmann
Mar 10, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·J Müller-HöckerA Sendelhofert
Jun 18, 2003·Journal of Cellular Physiology·Karin Milde-Langosch, Sabine Riethdorf
Aug 26, 1998·International Journal of Cancer. Journal International Du Cancer·K E PestellM I Walton
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·B NeynsJ De Grève
Nov 17, 2004·Acta Oncologica·Ivanka DimovaDraga Toncheva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.